MedTrace Logo

Time to Move in Pregnancy Hyperglycemia

NCT06125704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2026-04-29

No results posted yet for this study

Summary

This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will:

1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5am-9am, within 30-40 minutes of starting breakfast), versus late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on glucose across the 24-hour cycle.
2. Explore the potential effects of the timing of PA on sleep and mood state.

Conditions

  • GDM
  • Physical Activity
  • Hyperglycemia
  • Glucose Intolerance
  • Circadian Rhythm
  • Exercise

Interventions

BEHAVIORAL

Moderate intensity walking or stepping

30 minutes of moderate intensity walking or stepping (i.e., at a pace of approximately 100 steps per minute), varied by time of day it is performed: morning (i.e., between 5am-9am, within 30-40 minutes of starting breakfast) versus late afternoon/evening (i.e., between 4pm-8pm, within 30-40 minutes of dinner).

Sponsors & Collaborators

  • University of Tennessee Graduate School of Medicine

    collaborator OTHER

  • The University of Tennessee, Knoxville

    lead OTHER

Principal Investigators

  • Samantha Ehrlich, PhD · The University of Tennessee, Knoxville

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-06
Primary Completion
2025-11-24
Completion
2025-11-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06125704 on ClinicalTrials.gov